Nytricx
UEI: GF9DV4ACBHH8
• CAGE: 9DZ67
Overview
Awardee Type
Parent
Federal Capability Statement
Nytricx develops medical devices in which antimicrobial and antithrombotic nitric oxide-based coatings are applied to external and internal surfaces to prolong device function.
Keywords
medical devices
nitric oxide
antimicrobial
antithrombotic
SBA Special Equipment
Nitric oxide analyzers made by Zysense
Website
Headquarters
Athens, GA
United States
United States
Most Recent Award
Aug. 1, 2026
Calculating
Nytricx is a federal contract and grant recipient (UEI GF9DV4ACBHH8; CAGE 9DZ67). It is headquartered in Athens, GA. Its primary registered NAICS is 541715: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). The corporation was founded in February 2022 and federally registered in April 2026.
Federal Award Analysis
Nytricx federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
NYTRICX, INC.
DBA
NYTRICX INC
UEI
GF9DV4ACBHH8
CAGE Code
9DZ67
Primary NAICS
SBA Certifications
None
Self Certifications
Woman Owned Business
Woman Owned Small Business
Woman Owned Small Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Feb. 5, 2022
Initial Registration
April 6, 2026
Last Registration
April 8, 2026
Registration Activation
April 15, 2026
Registration Expiration
April 6, 2027
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
GA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No